Schedule 13D ownership disclosure

Melinta Therapeutics Inc

Security class unavailable · CUSIP: 58549G100

Event date: 2018-11-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
28.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-18-322611
Form type
SC 13D/A
Filer
MELINTA THERAPEUTICS, INC. /NEW/
CIK
CIK 1461993
Filed
Nov 08, 2018
Reporting period
Nov 06, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub